TMS Co (TSE:4891) Beta: 1.1158 (As of Jun. 25, 2026)


TSE:4891 TMS Co Ltd TSE:4891
33 GF Score
Price 円101.00
! 1 Warning Sign
View Full Analysis

What is TMS Co Beta?

TMS Co TSE:4891 33 Beta is 1.1158 as of Jun. 25, 2026. GuruFocus rates TSE:4891 with a GF Score™ of 33/100. The stock has 1 warning sign investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-25), TMS Co's Beta is 1.1158.


TMS Co  (TSE:4891) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


TMS Co Beta Related Terms


TMS Co Beta Historical Data

* Premium members only.

The historical data trend for TMS Co's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TMS Co Beta Chart

TMS Co Annual Data
Trend Feb21 Feb22 Feb23 Feb24 Feb25
Beta
0.00 0.00 0.00 0.00 0.00

TMS Co Quarterly Data
Feb21 Feb22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Feb25 May25 Aug25 Dec25
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 1.24

TSE:4891 vs VRTX, REGN, ALNY: Beta Comparison

For the Biotechnology subindustry, TMS Co's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TMS Co Beta vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TMS Co's Beta distribution charts can be found below:

* The bar in red indicates where TMS Co's Beta falls into.


TSE:4891
33GF Score
TMS Co Ltd TSE:4891
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TMS Co Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 1.1158 mean?
TMS Co (TSE:4891) has a Beta of 1.1158 as of Jun. 25, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for TMS Co and its competitors.
Is TMS Co's Beta too high?
TMS Co's current Beta is 1.1158. Overall, TMS Co has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does TMS Co's Beta compare to VRTX and REGN?
TMS Co's Beta of 1.1158 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Biotechnology company?
A good Beta depends on the Biotechnology industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for TMS Co and its competitors. TMS Co's current Beta is 1.1158. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TMS Co stock overvalued right now?
TMS Co (TSE:4891) has a current Beta of 1.1158. The current Beta is 1.1158. TMS Co's overall GF Score™ is 33/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For TMS Co (TSE:4891), the current Beta is 1.1158 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TMS Co Business Description

Address 1-9-11F, Fuchu-cho, Fuchu-shi, Tokyo, JPN, 183-0055
TMS Co Ltd is focused on researching, developing, manufacturing, and selling pharmaceuticals. The company is involved in conducting research and development of SMTP compounds, which are drug candidate substances targeting soluble epoxide hydrolase (sEH), an enzyme found in the human body. It is developing sEH inhibitors for various inflammatory diseases. The company's clinical pipeline comprises three compounds: TMS-007 (being developed as a potential treatment for acute cerebral infarction), which is in the late clinical stage, TMS-010, and JX09 (for resistant and poorly controlled hypertension) and TMS-008 (to target acute inflammatory diseases such as kidney injury and cancer cachexia), which are in the early clinical stage. In addition, it has TMS-009 as a backup compound for TMS-008.
33GF Score

Get the complete analysis for TSE:4891

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円101.00
Price